ELECT: Prospective, Randomized Trial Comparing Microvascular Plug versus Platinum-Fibered Microcoils for Embolization of Aneurysm Sac Side Branches before Endovascular Aortic Aneurysm Repair

Author:

Konert Manuela1ORCID,Schmidt Andrej2,Branzan Daniela2,Wittig Tim2,Scheinert Dierk2,Steiner Sabine2

Affiliation:

1. University Hospital Leipzig Department for Internal Medicine Neurology and Dermatology: Universitatsklinikum Leipzig Department fur Innere Medizin Neurologie und Dermatologie

2. University Hospital Leipzig: Universitatsklinikum Leipzig

Abstract

Abstract Background Preemptive selective embolization of aneurysm sac side branches (ASSBs) has been proposed to prevent type II endoleak after endovascular aortic aneurysm repair (EVAR). This study aimed to explore if an embolization strategy using microvascular plugs (MVP) reduces intervention time and radiation dose compared to platinum-fibered microcoils. Further, the effectiveness of the devices in occluding the treated artery was assessed. Methods Sixty patients scheduled for EVAR underwent percutaneous preemptive embolization of ASSBs using MVPs or coils after a 1:1 randomization. Follow-up imaging was performed during aortic stentgraft implantation. Results Overall, 170 ASSBs were successfully occluded (83 arteries by MVPs and 87 by coils) and no acute treatment failure occurred. The mean procedure time was significantly lower in the group treated with MVPs (55 ± 4 minutes) compared to coil occlusion (67 ± 3 minutes; p = 0.018), which was paralleled by a numerically lower radiation dose (119 Gy/cm2 vs. 140 Gy/cm2; p = 0.45). No difference was found for contrast agent use (34 ml MVP group vs 35 ml coil group; p = 0.87). At follow-up reopening of lumbar arteries was seen in nine cases (four after coil embolization; five after MVPs). Conclusion Both microvascular plugs and coils can be effectively used for preemptive embolization of aneurysm sac side branches before EVAR. Use of plugs offers a benefit in terms of intervention time. Trial registration ClinicalTrials.gov Identifier: NCT03842930 Registered 15 February 2019, https://classic.clinicaltrials.gov/ct2/show/NCT03842930

Publisher

Research Square Platform LLC

同舟云学术

1.学者识别学者识别

2.学术分析学术分析

3.人才评估人才评估

"同舟云学术"是以全球学者为主线,采集、加工和组织学术论文而形成的新型学术文献查询和分析系统,可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容,当前同舟云学术共收录了国内外主流学术期刊6万余种,收集的期刊论文及会议论文总量共计约1.5亿篇,并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询!咨询电话:010-8811{复制后删除}0370

www.globalauthorid.com

TOP

Copyright © 2019-2024 北京同舟云网络信息技术有限公司
京公网安备11010802033243号  京ICP备18003416号-3